| __timestamp | ADMA Biologics, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 31354781 |
| Thursday, January 1, 2015 | 7015946 | 43445817 |
| Friday, January 1, 2016 | 7688238 | 66489820 |
| Sunday, January 1, 2017 | 6229587 | 96886134 |
| Monday, January 1, 2018 | 3926120 | 153793000 |
| Tuesday, January 1, 2019 | 2343848 | 148369000 |
| Wednesday, January 1, 2020 | 5907013 | 151934000 |
| Friday, January 1, 2021 | 3646060 | 198532000 |
| Saturday, January 1, 2022 | 3613764 | 112128000 |
| Sunday, January 1, 2023 | 3300000 | 76192000 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, TG Therapeutics, Inc. and ADMA Biologics, Inc. have demonstrated contrasting strategies in their R&D investments.
TG Therapeutics has consistently outpaced ADMA Biologics, with its R&D expenses peaking in 2021 at nearly 200% higher than its 2014 levels. This aggressive investment strategy underscores TG Therapeutics' focus on expanding its therapeutic pipeline. In contrast, ADMA Biologics has shown a more conservative approach, with R&D spending decreasing by approximately 65% from 2014 to 2023.
These trends highlight the diverse strategies within the biotech sector, where companies balance innovation with financial sustainability. As the industry evolves, monitoring these investments will provide insights into future breakthroughs and market leadership.
Comparing Innovation Spending: Eli Lilly and Company and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and TG Therapeutics, Inc.
Comparing Innovation Spending: Merck & Co., Inc. and ADMA Biologics, Inc.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.
R&D Spending Showdown: Genmab A/S vs TG Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ADMA Biologics, Inc.
BioMarin Pharmaceutical Inc. vs TG Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
TG Therapeutics, Inc. vs ADMA Biologics, Inc.: Annual Revenue Growth Compared
TG Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for ADMA Biologics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and Viridian Therapeutics, Inc.